West Pharmaceutical Services

West delivers innovative solutions to improve the safe delivery of pharmaceutical, health care and personal care products and is the world’s premier manufacturer of components and systems for injectable drug delivery. We serve the world’s leading pharmaceutical and biopharmaceutical companies. Pharmaceutical, biopharmaceutical and medical device companies around the world rely on West Pharmaceutical Services, Inc. for standard-setting systems and device components for parenterally administered medicines. West applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer health care products. West Analytical Services applies decades of pharmaceutical industry drug product testing, development and packaging expertise to assist customers through the complex laboratory analysis associated with meeting drug product, stability, container closure and packaging regulatory guidelines. West’s professionals provide expertise to customers from early product development through full production. Our expertise helps mitigate risk, implement world-class production technologies and comply with global regulatory requirements. West has made substantial investments in products, processes and plants that will add value for customers now and in the future. The Tech Group, a West company, is a global leader in injection molding offering contract manufacturing solutions for pharmaceutical delivery systems, medical devices and personal care and consumer products. Medimop Medical Projects Ltd., a West company, is a leader in the world market for transfer, mixing and administration systems for injectable pharmaceuticals. Founded in 1923 with global headquarters in Lionville, Pennsylvania, West has a presence in North America, South America, Asia/Pacific, Middle East and Europe and 6,300 employees worldwide. The West name means assured top quality to the leaders of the global pharmaceutical industry. Customers rely on West’s packaging systems and components for safety, efficiency, reliability and leading-edge technologies that improve drug administration. Shares of West’s common stock are traded on the New York Stock Exchange under the symbol WST.
Company Growth (employees)
Type
Public
HQ
Exton, US
Founded
1923
Size (employees)
7,300 (est)
West Pharmaceutical Services was founded in 1923 and is headquartered in Exton, US

West Pharmaceutical Services Office Locations

West Pharmaceutical Services has an office in Exton
Exton, US (HQ)
530 Herman O. W Dr

West Pharmaceutical Services Data and Metrics

West Pharmaceutical Services Financial Metrics

West Pharmaceutical Services's revenue was reported to be $387.7 m in Q1, 2017
USD

Revenue (Q1, 2017)

387.7 m

Net income (Q1, 2017)

60.9 m

EBIT (Q1, 2017)

61.3 m

Market capitalization (17-Aug-2017)

6.5 b

Cash (31-Mar-2017)

169.4 m
West Pharmaceutical Services's current market capitalization is $6.5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.4 b1.4 b1.4 b1.5 b

Revenue growth, %

4%(2%)8%

Gross profit

434.7 m447.8 m455.8 m

Gross profit Margin, %

32%32%33%

R&D expense

36.8 m

General and administrative expense

239.8 m

Operating expense total

276.6 m

EBIT

162.4 m182 m128.6 m196.8 m

EBIT margin, %

12%13%9%13%

Interest expense

17 m16.5 m14.1 m8.1 m

Interest income

1.9 m3.5 m1.6 m1.1 m

Pre tax profit

147.1 m169 m116.1 m189.8 m

Income tax expense

40.2 m47.2 m26.3 m54.4 m

Net Income

112.3 m127.1 m95.6 m143.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

368.9 m355.9 m335.9 m359.7 m344.5 m362.1 m388 m376.7 m387.7 m

R&D expense

9.9 m9.6 m7.5 m8.1 m8.5 m9.4 m8.8 m9 m10.3 m

General and administrative expense

57.5 m56 m55.2 m60.8 m54.6 m58.1 m62.5 m58.3 m61.6 m

Operating expense total

67.4 m65.6 m62.7 m68.9 m63.1 m67.5 m71.3 m67.3 m71.9 m

EBIT

54.1 m44 m47.8 m39.1 m30 m61.2 m51.3 m61.3 m

EBIT margin, %

15%12%14%11%8%16%14%16%

Interest expense

4.2 m4.5 m4.1 m3.4 m3.7 m2.5 m2 m2.2 m2.1 m

Interest income

500 k1.8 m400 k400 k500 k300 k300 k200 k300 k

Pre tax profit

50.4 m41.3 m44.1 m36.1 m(6.7 m)27.8 m59.5 m49.3 m59.5 m

Income tax expense

14 m11.7 m12.5 m9.2 m(6.6 m)6.9 m17 m14.4 m2.2 m

Net Income

37.6 m31 m32.9 m27.8 m1.5 m22.1 m44.7 m37.6 m60.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

230 m255.3 m274.6 m203 m

Accounts Receivable

185.7 m179 m181.4 m200.5 m

Inventories

176.9 m181.5 m181.1 m199.3 m

Current Assets

650.7 m659.3 m673.7 m641.9 m

PP&E

711.7 m705.8 m721 m778.3 m

Goodwill

114.2 m108.6 m104.6 m103 m

Total Assets

1.7 b1.7 b1.7 b1.7 b

Accounts Payable

108 m103.1 m119.8 m122 m

Total Debt

226.2 m

Current Liabilities

236.9 m252.5 m314.3 m241 m

Total Liabilities

599.2 m

Additional Paid-in Capital

120 m160.2 m207.8 m260.4 m

Retained Earnings

805 m902.2 m964.6 m1.1 b

Total Equity

906.4 m956.9 m1 b1.1 b

Debt to Equity Ratio

0.2 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.8 x1.7 x1.7 x1.5 x
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

226.7 m246.8 m207.1 m252 m256.8 m178.1 m202.7 m205.9 m169.4 m

Accounts Receivable

209.6 m195.9 m189.5 m198.8 m194.6 m209.6 m219 m209.5 m224.8 m

Inventories

187.9 m185.7 m183.4 m187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m

Current Assets

685.4 m679.5 m625.1 m679.9 m680.9 m630.7 m659.2 m658.1 m652.6 m

PP&E

709.2 m694.8 m675.8 m685.4 m689.5 m732.5 m741.2 m772.7 m782.8 m

Goodwill

114 m110.4 m104.4 m105.3 m105.7 m105.7 m104.9 m105.2 m103.5 m

Total Assets

1.7 b1.7 b1.6 b1.7 b1.7 b1.7 b1.7 b1.7 b1.7 b

Accounts Payable

94.5 m91.4 m88.5 m91.4 m93.6 m97.5 m107.3 m99 m106.1 m

Current Liabilities

221.2 m242.5 m296.6 m313.7 m299.9 m241.1 m239.4 m236.8 m256.5 m

Additional Paid-in Capital

138.2 m149.1 m170.4 m188.6 m195.8 m238.5 m240.6 m247.6 m276 m

Retained Earnings

855.5 m878.7 m927.2 m947 m939.9 m978 m1 b1 b1.1 b

Total Equity

972.6 m970.1 m941.1 m989.4 m995.3 m1.1 b1.1 b1.1 b1.2 b

Financial Leverage

1.8 x1.7 x1.7 x1.7 x1.7 x1.6 x1.5 x1.5 x1.5 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

112.3 m127.1 m95.6 m143.6 m

Depreciation and Amortization

81 m84.8 m86.1 m88.1 m

Accounts Receivable

(9.1 m)(6.3 m)(14 m)(23.3 m)

Inventories

(14 m)(16 m)(11 m)(21.2 m)

Accounts Payable

4.6 m(3.5 m)17.2 m6.1 m

Cash From Operating Activities

220.5 m182.9 m212.4 m219.4 m

Capital Expenditures

(151.9 m)(111.9 m)(131.6 m)(170.2 m)

Cash From Investing Activities

(149.9 m)(104 m)(129.5 m)(175.8 m)

Long-term Borrowings

(30.5 m)(2.3 m)(27.4 m)(69.8 m)

Dividends Paid

(26.8 m)(29.1 m)(32.4 m)(35.8 m)

Cash From Financing Activities

(5.1 m)(30.8 m)(41.5 m)(113.9 m)

Interest Paid

16.9 m16.7 m14.7 m8.6 m

Free Cash Flow

372.4 m294.8 m344 m49.2 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

37.6 m31 m32.9 m27.8 m1.5 m22.1 m44.7 m37.6 m60.9 m

Accounts Receivable

198.8 m194.6 m209.6 m219 m209.5 m224.8 m

Inventories

187.2 m187.7 m194.1 m197.7 m201.1 m212.3 m

Accounts Payable

91.4 m93.6 m97.5 m107.3 m99 m106.1 m
USDY, 2017

Revenue/Employee

53.1 k

Financial Leverage

1.5 x

West Pharmaceutical Services Market Value History

West Pharmaceutical Services Median Salaries

Source: 17 public H-1B filings from West Pharmaceutical Services

Traffic Overview of West Pharmaceutical Services

West Pharmaceutical Services Online and Social Media Presence

West Pharmaceutical Services Company Life and Culture

You may also be interested in